Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active...
Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial
About this item
Full title
Author / Creator
Publisher
London: EULAR
Journal title
Language
English
Formats
Publication information
Publisher
London: EULAR
Subjects
More information
Scope and Contents
Contents
ObjectivesThe goal of this study was to identify protein and transcriptional biomarkers and pathways associated with baseline disease state, the effect of filgotinib (FIL) treatment on these biomarkers, and to investigate the mechanism of action of FIL on clinical improvement in patients with active psoriatic arthritis (PsA).MethodsThe phase II EQU...
Alternative Titles
Full title
Pharmacodynamic effects of filgotinib treatment driving clinical improvement in patients with active psoriatic arthritis enrolled in the EQUATOR trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9c27836f275b4d8487c241567f1373a4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9c27836f275b4d8487c241567f1373a4
Other Identifiers
ISSN
2056-5933
E-ISSN
2056-5933
DOI
10.1136/rmdopen-2023-003550
